GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 37 | |
SMR RATING 1..100 | 25 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 87 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 47% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 46% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 51% |
| MACD ODDS (%) | 2 days ago 82% | 2 days ago 40% |
| TrendWeek ODDS (%) | 2 days ago 74% | 2 days ago 49% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 57% |
| Advances ODDS (%) | 8 days ago 76% | 9 days ago 60% |
| Declines ODDS (%) | 2 days ago 76% | 17 days ago 50% |
| BollingerBands ODDS (%) | 2 days ago 69% | 2 days ago 47% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 51% |
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with HLN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then HLN could also see price increases.
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | -0.53% | ||
| HLN - EFAV | 62% Loosely correlated | -0.72% | ||
| AZN - EFAV | 57% Loosely correlated | +0.17% | ||
| DTE - EFAV | 53% Loosely correlated | -0.38% | ||
| SAN - EFAV | 52% Loosely correlated | -2.21% | ||
| GSK - EFAV | 51% Loosely correlated | -0.34% | ||
More | ||||